Someone recently suggested that low-dose naltrexone, or LDN, must be a scam because it does not “cure” disease. By that standard, however, most medications would also be considered scams, because many are designed to manage symptoms, reduce inflammation, improve function, or slow disease activity rather than provide a permanent cure. LDN may be helpful through two important mechanisms: 1. Endorphin support 2. 3. LDN temporarily blocks opioid receptors. In many people, the body responds by increasing its production of endorphins and related signaling molecules after the blockade wears off. 4. Inflammation and immune regulation 5. 6. LDN may help regulate inflammatory activity involving the immune system and nervous system. This is one reason it is being studied and used clinically for autoimmune conditions, chronic pain, neuroinflammation, and other complex immune or nervous system concerns. LDN is not a miracle cure, and it does not work for everyone. Some people are also unable to tolerate standard doses and may require much lower dosing or a different treatment approach. Its value is not that it cures every condition—it is that it may offer a unique combination of endorphin support, immune modulation, and nervous-system effects. This video is for educational purposes only and is not a substitute for individualized medical care.

Hydrogen sulfide small intestinal bacterial overgrowth — increasingly reclassified by leading gastroenterologists as Intestinal Sulfide Overproduction (ISO) — represents one of the most clinically challenging and underdiagnosed subtypes of gut dysbiosis. Unlike hydrogen-dominant SIBO (associated primarily with diarrhea) or methane-dominant SIBO/IMO (associated with constipation), ISO results from the unchecked proliferation of sulfate-reducing bacteria (SRBs) in the small intestine, producing hydrogen sulfide (H₂S) gas in pathological quantities. For decades, standard three-gas breath testing only measured hydrogen and methane, leaving ISO systematically invisible. The advent of the TrioSmart™ breath test (Gemelli Labs) — the first commercially available test to measure all three SIBO gases simultaneously — has finally given clinicians a diagnostic window into this condition. Even so, many patients with textbook ISO symptoms go years without a diagnosis, and formal treatment guidelines remain absent. This article synthesizes the current evidence base — including data presented at Digestive Disease Week (DDW) 2025 — to provide clinicians and informed patients with a practical, evidence-stratified approach to treating ISO/H₂S SIBO.

Hi! I've asked a bit about LDN and TBIs. New question: how can I explain that gabapentin is causing further damage when already experiencing symptoms of dementia at 40.. and how LDN will differ. Could starting LDN help sometime get off gabapentin? The main reason for that Rx is to help with sleep. Thank you!

Root Cause Analysis is used in Toyota and other high functioning organizations. We ought to use same concept to healing.